Cytopeutics®: Pioneering Stem Cell Research & Development

Cytopeutics® is the multi-award winning and trusted provider of  mesenchymal stem cells (MSC) for clinical trials and treatment in the Asia-Pacific region. With nearly two decades of evidence-based research and development, joint effort with scientists around the world, Cytopeutics® is also at the cutting edge of research exploring the potential of multicellular immunotherapy, including cytokine-induced killer cells (CIK) and polarized M2 macrophages.

Professional. Responsible. Evidence-based.

WORLD CLASS
CGMP LAB AND
CTX LICENSE
LONG TRACK RECORD
OF SAFETY AND
EFFICACY
PATENTED
IN THE USA with
LANDMARK RESEARCH

Cytopeutics® has concluded several clinical trial phase IIb/IIIa programs in partnerships with major universities and hospitals locally and internationally. These programs were approved by our ethics committees and national stem cell regulatory committee and registered with the US NIH registry.

Clinical Trial Programs

We are recognized by the Ministry of Health, with ongoing & completed clinical trial programs audited and approved by the National Stem Cell Research & Ethics Sub Committee and Medical Research Ethics Committee. In addition we are constantly striving to improve our cell quality and explore all of its potential through laboratory and animal research. 

 

Find out more about our research at various stages of development below:

Diabetes and Complications

Heart Attack, Heart Failure and Lung Disease

Stroke, Brain and Spinal Cord Injuries

Arthritis and Sport Injuries

Cancer, Infections

Autoimmune Diseases,
GVHD

Foot Ulcer, Poor Healing Wound

Kidney Disease

Eye Disease

Liver Disease
Dementia
Atherosclerosis
Atherosclerosis
Dementia

Hormonal Balance

Hair and Skin

Covid-19

Hormonal Balance

Hair and Skin

Covid-19

Determine Your Eligibility to Participate in Our Ongoing Clinical Trial Programs